About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Clinical Trials Support Service Market Size, Top Trends, Report to 2030
Clinical Trials Support Service Market

Clinical Trials Support Service Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Service (Clinical Trial Site Management, Patient Recruitment Management, Data Management, Administrative Staff, IRB, Others), By Sponsor (Pharmaceutical and Biopharmaceutical Companies, Medical Device Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI3428DR
Last Updated : July 19, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Clinical Trials Support Service Market Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Phase
        1. Introduction
          1. Phase By Value
        2. Phase I
          1. By Value
        3. Phase II
          1. By Value
        4. Phase III
          1. By Value
        5. Phase IV
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Site Management
          1. By Value
        3. Patient Recruitment Management
          1. By Value
        4. Data Management
          1. By Value
        5. Administrative Staff
          1. By Value
        6. IRB
          1. By Value
        7. Others
          1. By Value
      3. By Sponsor
        1. Introduction
          1. Sponsor By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Medical Device Companies
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Phase
        1. Introduction
          1. Phase By Value
        2. Phase I
          1. By Value
        3. Phase II
          1. By Value
        4. Phase III
          1. By Value
        5. Phase IV
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Site Management
          1. By Value
        3. Patient Recruitment Management
          1. By Value
        4. Data Management
          1. By Value
        5. Administrative Staff
          1. By Value
        6. IRB
          1. By Value
        7. Others
          1. By Value
      3. By Sponsor
        1. Introduction
          1. Sponsor By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Medical Device Companies
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Phase
        1. Introduction
          1. Phase By Value
        2. Phase I
          1. By Value
        3. Phase II
          1. By Value
        4. Phase III
          1. By Value
        5. Phase IV
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Site Management
          1. By Value
        3. Patient Recruitment Management
          1. By Value
        4. Data Management
          1. By Value
        5. Administrative Staff
          1. By Value
        6. IRB
          1. By Value
        7. Others
          1. By Value
      3. By Sponsor
        1. Introduction
          1. Sponsor By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Medical Device Companies
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Phase
        1. Introduction
          1. Phase By Value
        2. Phase I
          1. By Value
        3. Phase II
          1. By Value
        4. Phase III
          1. By Value
        5. Phase IV
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Site Management
          1. By Value
        3. Patient Recruitment Management
          1. By Value
        4. Data Management
          1. By Value
        5. Administrative Staff
          1. By Value
        6. IRB
          1. By Value
        7. Others
          1. By Value
      3. By Sponsor
        1. Introduction
          1. Sponsor By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Medical Device Companies
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Phase
      1. Introduction
        1. Phase By Value
      2. Phase I
        1. By Value
      3. Phase II
        1. By Value
      4. Phase III
        1. By Value
      5. Phase IV
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Site Management
        1. By Value
      3. Patient Recruitment Management
        1. By Value
      4. Data Management
        1. By Value
      5. Administrative Staff
        1. By Value
      6. IRB
        1. By Value
      7. Others
        1. By Value
    4. By Sponsor
      1. Introduction
        1. Sponsor By Value
      2. Pharmaceutical and Biopharmaceutical Companies
        1. By Value
      3. Medical Device Companies
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Phase
        1. Introduction
          1. Phase By Value
        2. Phase I
          1. By Value
        3. Phase II
          1. By Value
        4. Phase III
          1. By Value
        5. Phase IV
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Site Management
          1. By Value
        3. Patient Recruitment Management
          1. By Value
        4. Data Management
          1. By Value
        5. Administrative Staff
          1. By Value
        6. IRB
          1. By Value
        7. Others
          1. By Value
      3. By Sponsor
        1. Introduction
          1. Sponsor By Value
        2. Pharmaceutical and Biopharmaceutical Companies
          1. By Value
        3. Medical Device Companies
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Clinical Trials Support Service Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Charles River Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. The Pharmaceutical Product Development LLC
    3. Insight Genetics
    4. Eurofins Scientific SE
    5. IQVIA
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global clinical laboratory services market was valued at USD 219.60 billion in 2022. It is estimated to reach USD 332.02 billion by 2031, growing at a CAGR of 4.7% during the forecast period (2023–2031). Technological advancements in c
Buy Now
Global Report
The global clinical trails site market size was valued at USD 5.61 billion in 2021 and is projected to reach USD 9.65 billion by 2030 at a CAGR of 6.22% from 2022 to 2030. Factors such as investment in R&D and rising investments, significantly dr
Buy Now
Global Report
The global clinical trials software market size was valued at USD 1,233.34 million in 2023. It is expected to reach USD 4,525.57 million in 2032, growing at a CAGR of 15.54% over the forecast period (2024-32). Pharmaceutical companies and biotechnolo
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.